Influence of Nitrous Oxide on Minimum Alveolar Concentration of Sevoflurane for Laryngeal Mask Insertion in Children

Background Inhalational induction with sevoflurane and nitrous oxide is frequently used for Laryngeal Mask Airway ™ (LMA ™; Laryngeal Mask Company, Henley-on-Thames, United Kingdom) insertion in children. The authors determined the influence of nitrous oxide on the minimum alveolar concentration (MAC) of sevoflurane for LMA ™ insertion. Methods One hundred twenty unpremedicated children (age, 1–9 yr; American Society of Anesthesiologists physical status I) were randomly assigned to receive 1 of 15 end-tidal concentrations of nitrous oxide and sevoflurane for inhalational induction via a facemask: 0% nitrous oxide with 1.2, 1.4, 1.6, 1.8, or 2.0% sevoflurane; 33% nitrous oxide with 0.8, 1.0, 1.2, 1.4, or 1.6% sevoflurane; or 67% nitrous oxide with 0.4, 0.6, 0.8, 1.0, or 1.2% sevoflurane. The LMA ™ was inserted after steady state end-tidal anesthetic concentrations had been maintained for 15 min. The response to insertion was recorded by three independent blinded observers. The interaction between nitrous oxide and sevoflurane was determined using logistic regression analysis. Results The MAC of sevoflurane for LMA ™ insertion (95% confidence limit) was 1.57% (1.42–1.72%), and the concentration of sevoflurane required to prevent movement in 95% of children was 1.99% (1.81–2.57%). The addition of 33% and 67% nitrous oxide linearly decreased the MAC of sevoflurane for LMA ™ insertion by 22% and 49%, respectively (P < 0.001). The interaction coefficient between nitrous oxide and sevoflurane did not differ from zero (P = 0.7843), indicating that the relation was additive. Conclusions Nitrous oxide and sevoflurane suppress the responses to LMA ™ insertion in a linear and additive fashion in children.

[1]  A. Grabowska-Gaweł [End-tidal sevoflurane concentrations for laryngeal mask airway insertion and tracheal intubation in children]. , 2004, Przeglad lekarski.

[2]  R. Aantaa,et al.  Sevoflurane EC50 and EC95 values for laryngeal mask insertion and tracheal intubation in children. , 2001, British journal of anaesthesia.

[3]  S. Inomata,et al.  The Awakening Concentration of Sevoflurane in Children , 2000, Anesthesia and analgesia.

[4]  J. Lerman,et al.  Additive contribution of nitrous oxide to sevoflurane minimum alveolar concentration for tracheal intubation in children. , 1999, Anesthesiology.

[5]  J. Lerman,et al.  The Pharmacology of Sevoflurane in Infants and Children , 1994, Anesthesiology.

[6]  S. Inomata,et al.  End‐tidal Sevoflurane Concentration for Tracheal Intubation and Minimum Alveolar Concentration in Pediatric Patients , 1994, Anesthesiology.

[7]  M. Zwass,et al.  MAC of desflurane in 60% nitrous oxide in infants and children. , 1992, Anesthesiology.

[8]  K. Ikeda,et al.  Minimum alveolar concentration of sevoflurane in children. , 1992, British journal of anaesthesia.

[9]  D. Murray,et al.  The additive contribution of nitrous oxide to isoflurane MAC in infants and children. , 1991, Anesthesiology.

[10]  D. Murray,et al.  Additive Contribution of Nitrous Oxide to Halothane MAC in Infants and Children , 1990, Anesthesia and analgesia.

[11]  K. Ikeda,et al.  The Minimum Alveolar Concentration (MAC) of Sevoflurane in Humans , 1987, Anesthesiology.